Key facts
- This page summarizes Jonathan Schechter's Form 4 filing for PharmaCyte Biotech, Inc. (PMCB).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jan 2026, 17:43.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Purchase